September 06, 2017
1 min read
Save

Cardiology Today's Intervention top articles posted in August

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Cardiology Today’s Intervention compiled a list of the top 5 stories posted to Healio.com/Cardiology in August.

This month, Cardiology Today’s Intervention readers were most interested in CABG treatment in patients with type 1 diabetes and multivessel disease, the results of the RE-DUAL PCI, BIOFLOW-V, PACIFY and VALIDATE-SWEDEHEART trials, and much more.

 

CABG superior to PCI in patients with type 1 diabetes, multivessel disease

Compared with PCI, CABG was associated with less risk for CHD mortality, MI and repeat revascularization in patients with type 1 diabetes and multivessel disease, researchers reported.

Read More

RE-DUAL PCI: Dabigatran plus P2Y12 inhibitor lowers bleeding risk vs. triple therapy

For patients with atrial fibrillation undergoing PCI, bleeding risk was lower in those assigned dabigatran plus a P2Y12 inhibitor compared with those assigned warfarin plus a P2Y12 inhibitor plus aspirin, according to results published in The New England Journal of Medicine.

Read More

 

BIOFLOW-V: Bioresorbable polymer DES superior to durable polymer DES for 12-month TLF

An ultra-thin sirolimus-eluting bioresorbable polymer drug-eluting stent was superior to a thin everolimus-eluting durable polymer stent for prevention of target lesion failure at 12 months, according to a late-breaking presentation from the European Society of Cardiology Congress.

Read More

 

PACIFY: Fentanyl delays absorption of ticagrelor during PCI

Administering IV fentanyl during PCI delayed the absorption of ticagrelor by as many as 4 hours, according to a poster presented at the European Society of Cardiology Congress.

Read More

 

VALIDATE-SWEDEHEART: Bivalirudin not superior to heparin in PCI for MI

Patients with MI undergoing PCI had similar outcomes regardless of whether they were anticoagulated with bivalirudin or heparin, according to new data from the VALIDATE-SWEDEHEART study published in The New England Journal of Medicine.

Read More